AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook or LinkedIn.
|Intraday High||52 Week High|
|Intraday Low||52 Week Low|
|Today's Open||Currency||US Dollar|
Copyright Nasdaq. Minimum 15 minutes delayed.
07/27/18 8:00 am CDT
AbbVie to Host Second-Quarter 2018 Earnings Conference CallSupporting Materials
06/12/18 10:00 am CDT
AbbVie to Present at the Goldman Sachs 39th Annual Global Healthcare Conference